Net profit of Glaxosmithkline Pharmaceuticals rose 16.09% to Rs 252.50 crore in the quarter ended September 2024 as against Rs 217.51 crore during the previous quarter ended September 2023. Sales rose 5.62% to Rs 1010.77 crore in the quarter ended September 2024 as against Rs 956.99 crore during the previous quarter ended September 2023.
Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
Sales | 1010.77 | 956.99 | 6 |
OPM % | 31.83 | 30.25 | - |
PBDT | 355.98 | 317.27 | 12 |
PBT | 339.12 | 299.16 | 13 |
NP | 252.50 | 217.51 | 16 |